Beaudry H, Proteau-Gagné A, Li Shuang, Dory Y, Chavkin C, Gendron L
Department of Physiology and Biophysics, Université de Sherbrooke, Faculty of Medicine, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada.
Neuroscience. 2009 Jun 30;161(2):381-91. doi: 10.1016/j.neuroscience.2009.03.053. Epub 2009 Mar 27.
In the present study, we asked whether multiple intrathecal injections of deltorphin II, a selective delta opioid receptor (DOPR) agonist, induced DOPR tolerance in three behavioral assays. Unilateral inflammation caused by complete Freund's adjuvant (CFA) injection into the rat or mouse hind paw (CFA model) induced thermal hyperalgesic response that was transiently and dose-dependently reduced by intrathecal administration of deltorphin II or morphine. In both rodent species, the effect of deltorphin II was not modified by a single prior administration of deltorphin II, suggesting an absence of acute tolerance in this paradigm. Repeated administration of intrathecal deltorphin II or s.c. SB-235863 (five consecutive injections over 60 h) also failed to impair the antihyperalgesic response to delta opioid receptor agonist, whereas repeated intrathecal or s.c. injections of morphine induced a significant decrease in the subsequent thermal antihyperalgesic response to morphine. In mice, deltorphin II also induced a rapid, transient motor incoordination/ataxia-like behavior as tested with the accelerating rotarod. In contrast to the antihyperalgesic responses, tolerance to the motoric effect of deltorphin II was evident in mice previously exposed to multiple intrathecal agonist injections, but not multiple saline administrations. Using the tail flick antinociceptive test, we found that DOPR-mediated analgesia was significantly reduced by repeated exposure to deltorphin II. Altogether, these observations suggest that repeated injections of DOPR agonists induce differential tolerance effects on antihyperalgesic, antinociceptive, and motor incoordination/ataxia-like behaviors related to DOPR activation by deltorphin II.
在本研究中,我们探究了鞘内多次注射选择性δ阿片受体(DOPR)激动剂德尔托啡肽II是否会在三种行为测定中诱导DOPR耐受性。向大鼠或小鼠后爪注射完全弗氏佐剂(CFA)引起的单侧炎症(CFA模型)会诱导热痛觉过敏反应,鞘内注射德尔托啡肽II或吗啡可使其短暂且剂量依赖性地减轻。在这两种啮齿动物中,单次预先注射德尔托啡肽II并不会改变德尔托啡肽II的作用,这表明在此范式中不存在急性耐受性。重复鞘内注射德尔托啡肽II或皮下注射SB - 235863(在60小时内连续注射五次)也未能削弱对δ阿片受体激动剂的抗痛觉过敏反应,而重复鞘内或皮下注射吗啡则会导致随后对吗啡的热抗痛觉过敏反应显著降低。在小鼠中,用加速转棒试验测试发现,德尔托啡肽II还会诱导快速、短暂的运动不协调/共济失调样行为。与抗痛觉过敏反应不同,先前接受多次鞘内激动剂注射的小鼠对德尔托啡肽II的运动效应产生了耐受性,但多次注射生理盐水的小鼠则没有。使用甩尾镇痛试验,我们发现重复接触德尔托啡肽II会使DOPR介导的镇痛作用显著降低。总之,这些观察结果表明,重复注射DOPR激动剂会对与德尔托啡肽II激活DOPR相关的抗痛觉过敏、镇痛和运动不协调/共济失调样行为产生不同的耐受性影响。